ARCHIVES

Anamorelin Increases Body Mass In Two Global Phase III Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Preoperative Drug Combo Benefits HER-2 Breast Cancer

April 29, 2005

Contracts Cutback Canceled 7 RFPs

August 8, 1980

New Drugs And Older Ones In New Uses Show Progress Against Several Cancers

April 25, 2008

NCI Official Says He Hopes to “Put More Money” Into SPOREs.

April 14, 2006

Other News: ESAs Fail To Reduce Blood Transfusions, SEER Data Show

November 20, 2009

Terry To Leave As DRCCA Acting Director Sept. 1, Peter Greenwald Is DeVita’s Choice For The Job

August 14, 1981